TScan Therapeutics, Inc. (TCRX)
USD 1.12
(1.82%)
USD 1.12
(1.82%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -61.35 Million | -66.5 Million | -48.67 Million | -3.02 Million | -12.52 Million |
| Net Income | -89.21 Million | -66.22 Million | -48.62 Million | -26.12 Million | -13.65 Million |
| Depreciation & Amortization | 5.36 Million | 5.13 Million | 3.32 Million | 1.23 Million | 519 Thousand |
| Deferred income taxes | 52 Thousand | - | -9.16 Million | - | - |
| Stock-based compensation | 5.2 Million | 4.55 Million | 2.51 Million | 515 Thousand | 240 Thousand |
| Change in working capital | 17.6 Million | -10.23 Million | -5.89 Million | 21.35 Million | 299 Thousand |
| Other non-cash items | -367 Thousand | 260 Thousand | 9.16 Million | 2000.00 | 78 Thousand |
| Investing Cash Flow | -60.75 Million | -4.22 Million | -9.94 Million | -4.23 Million | -1.24 Million |
| Investments in PPE | -3.14 Million | -4.22 Million | -9.94 Million | -4.23 Million | -1.24 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -77.61 Million | - | - | - | - |
| Sales/Maturities of investments | 20 Million | - | - | - | - |
| Other Investing Activities | -57.61 Million | - | - | - | - |
| Financing Cash Flow | 135.44 Million | 29.35 Million | 189.66 Million | 288 Thousand | 34.81 Million |
| Debt repayment | - | -324 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 135.44 Million | 193 Thousand | 89.64 Million | 288 Thousand | 34.81 Million |
| Other Financing Activities | 135.44 Million | 29.48 Million | 100.02 Million | 288 Thousand | 34.81 Million |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | -52 Thousand | 528 Thousand | 10 Thousand | 1.12 Million | 161 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | 17.65 Million | -10.75 Million | -5.9 Million | 20.23 Million | 138 Thousand |
| Cash at beginning of period | 120.02 Million | 166.43 Million | 35.38 Million | 42.35 Million | 21.31 Million |
| Cash at end of period | 133.35 Million | 125.06 Million | 166.43 Million | 35.38 Million | 42.35 Million |
| Capital Expenditure | -3.14 Million | -4.22 Million | -9.94 Million | -4.23 Million | -1.24 Million |
| Effect of forex changes on cash | 6000.00 | - | - | - | - |
| Net cash flow / Change in cash | 13.33 Million | -41.37 Million | 131.05 Million | -6.97 Million | 21.04 Million |
| Free Cash Flow | -64.5 Million | -70.72 Million | -58.61 Million | -7.26 Million | -13.76 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -31.66 Million | -30.14 Million | -19.61 Million | -89.21 Million | -22.99 Million | -24.04 Million |
| Depreciation & Amortization | 1.11 Million | 1.25 Million | 1.28 Million | 5.36 Million | 1.28 Million | 1.29 Million |
| Deferred income taxes | - | - | -4.7 Million | 52 Thousand | -235 Thousand | - |
| Stock-based compensation | 2.32 Million | 1.98 Million | 1.5 Million | 5.2 Million | 1.34 Million | 1.22 Million |
| Change in working capital | 2.18 Million | -2.1 Million | -6.19 Million | 17.6 Million | 28.39 Million | -711 Thousand |
| Other non-cash items | 3.97 Million | 4.64 Million | 3.96 Million | -367 Thousand | 223 Thousand | 218 Thousand |
| Investing Cash Flow | -33.71 Million | 36.16 Million | 1.91 Million | -60.75 Million | -61.41 Million | -420 Thousand |
| Investments in PPE | -862 Thousand | -705 Thousand | -469 Thousand | -3.14 Million | -1.41 Million | -420 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -48.35 Million | -8.77 Million | -17.61 Million | -77.61 Million | -59.99 Million | - |
| Sales/Maturities of investments | 15.5 Million | 45.64 Million | 20 Million | 20 Million | - | - |
| Other Investing Activities | -32.85 Million | 36.86 Million | 2.38 Million | -57.61 Million | -59.99 Million | - |
| Financing Cash Flow | 161.58 Million | 258 Thousand | 19 Thousand | 135.44 Million | -252 Thousand | 135.67 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 176 Thousand | - | -176 Thousand | - |
| Common Stock Issuance | 161.58 Million | 258 Thousand | 19 Thousand | 135.44 Million | -252 Thousand | 135.67 Million |
| Other Financing Activities | 161.58 Million | 258 Thousand | 19 Thousand | 135.44 Million | -76 Thousand | 135.67 Million |
| Accounts receivables | - | - | - | - | 31.92 Million | -31.92 Million |
| Accounts payables | 396 Thousand | -410 Thousand | -641 Thousand | -52 Thousand | -273 Thousand | 367 Thousand |
| Inventory | - | - | - | - | -31.92 Million | 31.92 Million |
| Other working capital | 1.78 Million | -1.69 Million | -5.55 Million | 17.65 Million | 28.67 Million | -1.07 Million |
| Cash at beginning of period | 140.51 Million | 133.35 Million | 155.19 Million | 120.02 Million | 213.87 Million | 100.63 Million |
| Cash at end of period | 242.15 Million | 140.51 Million | 133.35 Million | 133.35 Million | 160.22 Million | 213.87 Million |
| Capital Expenditure | -862 Thousand | -705 Thousand | -469 Thousand | -3.14 Million | -1.41 Million | -420 Thousand |
| Effect of forex changes on cash | - | - | 52.63 Million | 6000.00 | 55.86 Million | -108.5 Million |
| Net cash flow / Change in cash | 101.64 Million | 7.15 Million | -21.83 Million | 13.33 Million | -53.64 Million | 113.23 Million |
| Free Cash Flow | -27.08 Million | -29.97 Million | -24.23 Million | -64.5 Million | 6.59 Million | -22.44 Million |
0QKP
BTC
6558
603559
688039
2738